Showing results (1821-1830 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|November 26, 2008
The afterlife of drugs and the role of pharmEcovigilanceChristian G Daughton, Ilene Sue Ruhoy
Drug Safety|November 26, 2008
Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive reviewStephen Toovey, Craig Rayner, Eric Prinssen, et al.
Drug Safety|April 3, 2009
Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopeniaMarcie J Hursting, Joseph Soffer
Drug Safety|April 3, 2009
Risk management and outcomes of adverse events to pioglitazone in primary care in the UK: an observational studyCarole Fogg, Rachna Kasliwal, Saad A W Shakir
Drug Safety|April 3, 2009
Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the NetherlandsEugène van Puijenbroek, Jean Conemans, Kees van Grootheest
Drug Safety|February 18, 2010
New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisitedPhilippe Paquet, Gérald E Piérard
Drug Safety|May 31, 2017
The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of DelawareMaricruz Vega, Manisha Verma, David Beswick, et al.
Drug Safety|September 18, 2016
A Survey of Adverse Event Reporting Practices Among US Healthcare ProfessionalsStella Stergiopoulos, Carrie A Brown, Thomas Felix, et al.
Drug Safety|September 18, 2016
Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean PatientsGrace Juyun Kim, Soo Youn Lee, Ji Hye Park, et al.
Drug Safety|September 18, 2016
Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV PatientsRaymond A Tetteh, Edmund T Nartey, Margaret Lartey, et al.
Pageof 311